Gritstone Oncology (GRTS) PT Raised to $35 at BTIG on TCell Booster Royalties
Tweet Send to a Friend
BTIG analyst Thomas Shrader raised the price target on Gritstone Oncology (NASDAQ: GRTS) to $35.00 (from $17.00) on the belief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
